About me

CEODenise Hoblingre

After over 20 years of success in the corporate finance, Denise joined Keranova from the beginning in 2016 to manage the financial strategy and development, with a view to establishing Keranova as a recognized player in the cataract surgery.

Before joining Keranova, Denise held several managing positions in different international banking groups, including HSBC.
Then she advised different MedTech companies on strategic and financial transactions, including E-Ophtalmo, PhysioAssist and Carthera.

Denise is very involved in deeptech and is also a member of the board of directors of French Tech St Etienne Lyon.


About Denise Hoblingre

Denise holds a master’s degree in finance from Dijon Business School (BSB) and an International Certificate in Corporate Finance from HEC Paris.
Her background and strong knowledge of the regulation and the financial processes are essential to support the development of KERANOVA since its creation.


Michel Therin
DVM, PhD, Chairman of the BoardMichel Therin
Valérie Calenda
PhD, partner at Mérieux Développement Investment FundValérie Calenda
Celia Hart
PhD, General Partner at Supernova Invest FundCelia Hart
Philippe Tourrette
President Tourrette Investissement FundPhilippe Tourrette
Louis Geslin
PharmD, Observer - Financière Arbevel.Louis Geslin